Publications by authors named "J Seligmann"

Claim this Profile
C
Corrigendum to "Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population": [Ann Oncol 36 (2025) 520-528].
J F Seligmann, D Morton, F Elliott, K Handley, R Gray

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC).
J Seligmann, T Koessler, M Mauer, S Evrard, J Freedman

ESMO Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT Staging Performance in an International Trial of Neoadjuvant Chemotherapy for locally advanced Colon cancer.
James R Platt, Faye Elliott, Kelly Handley, Laura Magill, Philip Quirke, Jenny Seligmann

Br J Radiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the MAP Kinase Pathway in Colorectal Cancer: A Journey in Personalized Medicine.
Jordan W Appleyard, Christopher J M Williams, Paolo Manca, Filippo Pietrantonio, Jenny F Seligmann

Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative.
J Taieb, J Seligmann, D Modest, C Girault, F Rivera

ESMO Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis